Research map: Management of BK Polyomavirus in a Kidney Transplant Recipient With Primary Myelofibrosis on JAK-2 Inhibition – A Case Report and Literature Review

Back to the article

Papers in this map

  1. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia · Daniel A. Arber · 2016 · 10386 citations · Cited by this paper
  2. Randomized Controlled Trial of Intradialytic Cycling as Kidney Exercise Rehabilitation for Cardiac Stunning in Hemodialysis (TICKERS_HD): A Clinical Research Protocol · 2026 · Related
  3. The JAK/STAT signaling pathway: from bench to clinic · Xiaoyi Hu · 2021 · 2632 citations · Cited by this paper
  4. Vitamin D and Muscle Function in a Diverse Hemodialysis Cohort · 2025 · Related
  5. Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis · Steven R. Ytterberg · 2022 · 1819 citations · Cited by this paper
  6. Prevalence and Severity of Pruritus in Patients on Hemodialysis: A Cross-Sectional Study · 2025 · Related
  7. The JAK-STAT Pathway: Impact on Human Disease and Therapeutic Intervention · John J. O’Shea · 2015 · 1633 citations · Cited by this paper
  8. Revamping the KRESCENT Core Curriculum: The KRESCENT 2.0 Program Report · 2026 · Related
  9. Safety and Efficacy of Fedratinib in Patients With Primary or Secondary Myelofibrosis · Animesh Dev Pardanani · 2015 · 487 citations · Cited by this paper
  10. Acceptability of and Barriers to Continuous Glucose Monitoring in Individuals with Type 2 Diabetes Mellitus Receiving Chronic Hemodialysis: Research Letter · 2026 · Related
  11. Clinical significance of Janus Kinase inhibitor selectivity · Ernest Choy · 2018 · 286 citations · Cited by this paper
  12. HLA Experts’ Perspectives on Precision Medicine and Molecular Matching in Kidney Transplantation: A Qualitative Study · 2026 · Related
  13. JAK Inhibitors in Rheumatoid Arthritis: An Evidence-Based Review on the Emerging Clinical Data · Robert D. Harrington · 2020 · 244 citations · Cited by this paper
  14. Perioperative Care of Kidney Transplant Recipients: A Cross-Sectional Canadian Multidisciplinary Survey · 2026 · Related
  15. The Second International Consensus Guidelines on the Management of BK Polyomavirus in Kidney Transplantation · Camille N. Kotton · 2024 · 170 citations · Cited by this paper
  16. Benefits and Challenges When Implementing Incremental Hemodialysis: A Qualitative Study of Patients and Providers · 2025 · Related
  17. Randomized Phase 2b Trial of Tofacitinib (CP-690,550) in De Novo Kidney Transplant Patients: Efficacy, Renal Function and Safety at 1 Year · Flavio G. Vincenti · 2012 · 168 citations · Cited by this paper
  18. Sexual and Gender Minorities in Organ and Tissue Donation and Transplantation (OTDT): A Survey of Canadian OTDT Health Care Workers · 2026 · Related
  19. Calcineurin-Inhibitor-Free Immunosuppression Based on the JAK Inhibitor CP-690,550: A Pilot Study in De Novo Kidney Allograft Recipients · Stéphan Busque · 2009 · 154 citations · Cited by this paper
  20. Advancing Equity, Diversity, Inclusion, and Accessibility in a Patient-Oriented Kidney Research Network: A Can-SOLVE CKD Program Report · 2026 · Related
  21. Ruxolitinib in cytopenic myelofibrosis: Response, toxicity, drug discontinuation, and outcome · Francesca Palandri · 2023 · 46 citations · Cited by this paper
  22. Monitoring of the Immunomodulatory Effect of CP-690,550 by Analysis of the JAK/STAT Pathway in Kidney Transplant Patients · Monique E. Quaedackers · 2009 · 43 citations · Cited by this paper
  23. Jakinibs of All Trades: Inhibiting Cytokine Signaling in Immune-Mediated Pathologies · Madison T. Alexander · 2021 · 41 citations · Cited by this paper
  24. Targeting JAK/STAT Signaling to Prevent Rejection After Kidney Transplantation · Carla C. Baan · 2016 · 34 citations · Cited by this paper
  25. Efficacy and Safety of a Tofacitinib-based Immunosuppressive Regimen After Kidney Transplantation: Results From a Long-term Extension Trial · Stéphan Busque · 2018 · 30 citations · Cited by this paper
  26. Population Pharmacokinetic Analysis of Mycophenolic Acid Coadministered With Either Tasocitinib (CP-690,550) or Tacrolimus in Adult Renal Allograft Recipients · Manisha Lamba · 2010 · 19 citations · Cited by this paper
  27. Safety and Effectiveness of Janus Kinase Inhibitors in the Management of Inflammatory Bowel Disease Following Liver Transplantation · Danny Con · 2024 · 11 citations · Cited by this paper

Source: OpenAlex (CC0)